Bartter syndrome Normotensive
Hypokalemia / Hypercalciuria / Polydepsia / Polyuria
Hemolytic-uremic syndrome
Clinical Dx / Supportive therapy HD
Thrombotic thrombocytopenic purpura
FSGS / Focal segmental glomerulosclerosis / Nephrotic Syndrome
Hypocomplementemia in Renal Disease
• Membranoproliferative GN • Atheroemboli • Lupus • Cryoglobulinemia • Post-infectious GN
Membranoproliferative Glomerulonephritis:
• Low complement, hematuria, HTN / Tram traks • Tumors and CLL • Infections — endocarditis, hepatitis B/C • Mixed essential cryoglobulinemia • Systemic lupus erythematosus
Henoch-Schb’nlein purpura
Behcet’s syndrome
Alport Syndrome
Nephronophthisis-MCD Complex Medullary CYSTIC kidney vs MEDULLARY SPONGE KIDNEY
• Polyuria, polydipsia, anemia, FTT, retinitispigmentosa, * NORMAL U/A • Medullary CYSTIC kidney - progressiveto ESRD * MEDULLARY SPONGE KIDNEY * - “Paintbrush” pattern / Nephrolithiasis, hematuria - Urinary tract infections / Decreased concentrating ability - *** Good prognosis
von Hippel-Lindau (Cystic dz)
Name the Diuretics that work on these section of CT. Proxima CT: diuretics Loop: diuretics Distal CT: diuretics
Proxima CT: diuretics Acetazolamide / AE:Metabolic acidosis Loop: diuretics furosemide Like “Bartter’s” AE: Hearing loss if > 500 mg a day Distal CT: diuretics thiazides Like “Gittleman’s” A/E HypoNa, hypergly, hyperCa, bone marrow suppression
Increased BUN
Prerenal - Hepatorenal syndrome *
Prerenal Azotemia (~ 70%)
Acute Tubular Necrosis
• associated with ischemia and/or nephrotoxins - < 500 mL/day or < 20 mUhr/ Diuretics do NOT change prognosis * - Prototypically runs a 3-week course Acute Tubular Necrosis: Ischemic - U/A: muddy brown granular casts, * RTEs, FENa>1%
Acute Tubular Necrosis: Management / timing
• Aminoglycoside-induced renal failure — time lag 7-10 days • Amphotericin B - K/Mg waste, dRTA, concentration defect • Cisplatin: Mg wasting • Contrast-induced renal failure / Mgmt: need to establish euvolemia
Indications for Dialysis
Contraindications to Transplant
• Active infection • Uncontrollable malignancy • Anti-GBM antibodies • ABO incompatibility • Antilymphocyte antibodies against donor
Renal Transplantation * DZ that cause loss of a transplanted kidney
Major Transplant Drugs Groups
• Corticosteroids • Purine analogs / Azathioprine (Imuran) / Mycophenolate mofetil (CellCept) • Calcineurin Inhibitors/ Cyclosporine (Neoral, Sandimmune,Gengraf) / Tacrolimus (Prograf) • Antiproliferatives / Sirolimus (Rapamune)
A/E - Calcineurin Inhibitors/ Cyclosporine (Neoral, Sandimmune,Gengraf) / Tacrolimus (Prograf)
A/E – Corticosteroids
A/E – Antiproliferatives
anemia, thrombocytopenia, leukopenia, hepatoxicity, infections, posttransplant malignancy, Gl toxicities